Jun 28, 2023 | Patient Advocacy, Resources
Ela Lourido, Vice President and General Manager, Specialty Pharmacy Services Research shows that Biologics by McKesson’s pioneering risk-based care program maximizes patients’ time on therapy, leading to better oncology patient outcomes. Now, its partnership with...
May 10, 2023 | Video Transcripts
Biologics by McKesson Patient Voice Spotlight – Dan W. Yvonne Sims, Senior Manager, Marketing, Biologics by McKesson: So take us to 2021. Describe your health and what ultimately led to your diagnosis. Dan W., Biologics by McKesson Oncology Patient: I noticed...
Apr 5, 2023 | Press Release
CARY, N.C., April 5, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Reata Pharmaceuticals as the sole specialty pharmacy provider for SKYCLARYSTM (omaveloxolone), the first and only treatment...
Feb 14, 2023 | Press Release
CARY, N.C., Feb. 14, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Lilly as a specialty pharmacy provider for JAYPIRCA™ (pirtobrutinib) for the treatment of adult patients with...
Feb 10, 2023 | Press Release
CARY, N.C., Feb. 10, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Stemline Therapeutics Inc., as a limited distribution network specialty pharmacy provider for ORSERDU™ (elacestrant)....